AVS Bio acquires Biorbyt to expand global biomaterials platform
AVS Bio has acquired Biorbyt, expanding its global life-sciences platform with a catalogue of more than one million antibodies, proteins and other research reagents.
The acquisition adds Biorbyt's ecommerce, distribution and biomaterials portfolio to AVS Bio's existing capabilities serving pharmaceutical, biotechnology and academic research customers.
The deal strengthens AVS Bio's position as a broader supplier of biological research products and supporting infrastructure across drug discovery and life-science development.
Field | Content |
Alert Type | Deal |
Companies | AVS Bio; Biorbyt |
Deal Type | Acquisition |
Asset or Company | Biorbyt Ltd |
Sector | Life-sciences research products; biomaterials |
Technology or Modality | Antibodies; proteins; bio-reagents; research materials |
Product Catalogue | More than one million research products |
Deal Value | Financial terms were not disclosed |
Geography | Global |
What Happened | AVS Bio acquired Biorbyt, adding its extensive research-product catalogue and global ecommerce capabilities. |
Why It Matters | The transaction broadens AVS Bio's offering across the research supply chain and expands its reach with pharmaceutical, biotechnology and academic customers. |
Supporting Context | Biorbyt supplies antibodies, proteins and other biological research reagents through a global ecommerce and distribution platform. |
Strategic Rationale | AVS Bio gains additional catalogue depth, digital distribution capability and access to a wider international customer base. |
Potential Impact | The acquisition could strengthen procurement options for researchers and create a larger integrated platform for biological research materials. |
Key Takeaway | AVS Bio has acquired Biorbyt to expand its global biomaterials and research-reagent platform. |
What to Watch | Integration of product catalogues, international distribution expansion and further acquisitions by AVS Bio. |
Primary Source | AVS Bio / Biorbyt |
Relevant Date | 23 September 2026 |
Discover how nuaxia can support your next medical education initiative:
Find out more about our specialist services - Moore's Outcome Assessments, Educational Needs Assessments and Patient Impact Studies for the Medical Education sector
Contact us on: support@nuaxia.com
Commentaires